FDA Approves Weekly Factor Therapy for Hemophilia A

(MedPage Today) -- The FDA has approved the recombinant antihemophilic factor Fc-VWF-XTEN fusion protein-ehtl (Altuviiio) for the treatment of adults and children with hemophilia A, Sanofi announced on Thursday. The first-in-class factor VIII...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news